z-logo
Premium
Microalbuminuria and retinopathy in adolescents and young adults with type 1 and type 2 diabetes
Author(s) -
Ek Anna E.,
Samuelsson Ulf,
Janson Annika,
Carlsson Annelie,
Elimam Amira,
Marcus Claude
Publication year - 2020
Publication title -
pediatric diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 75
eISSN - 1399-5448
pISSN - 1399-543X
DOI - 10.1111/pedi.13074
Subject(s) - medicine , microalbuminuria , type 2 diabetes , diabetes mellitus , retinopathy , type 1 diabetes , hazard ratio , diabetic retinopathy , pediatrics , albuminuria , confidence interval , endocrinology
Aim To estimate the occurrence of complications related to early‐onset type 2 diabetes compared with type 1 diabetes. Methods All individuals registered in the Swedish Pediatric Quality Diabetes Register and the Swedish National Diabetes Register with type 2 diabetes diagnosis at 10 to 25 years of age between 1996 and 2014 (n = 1413) were included. As controls, individuals with type 1 diabetes were randomly selected from the same registers and were matched for age, sex, and year‐of‐onset (n = 3748). Results Of the adolescents with type 2 diabetes in the pediatric register, 7.7% had microalbuminuria and 24.6% had signs of retinopathy 5 years after diagnosis, whereas the adolescents with type 1 diabetes 3.8% had microalbuminuria and 19.2% had retinopathy. Among the young adults with type 2 diabetes from the adult diabetes register 10 years after diagnosis 15.2% had microalbuminuria and 39.7% retinopathy, whereas the young adults with type 1 diabetes 4.8% had microalbuminuria and 43.8% retinopathy. After adjustment for established risk factors measured over time in the whole combined cohort, individuals with type 2 diabetes had significantly higher risk of microalbuminuria with a hazard ratio (HR) of 3.32 (95% confidence interval, CI 2.86‐3.85, P  < .001), and retinopathy with a HR of 1.17 (95% CI 1.06‐1.30, P 0.04). Conclusions The prevalence of complications and comorbidities was higher among those with type 2 diabetes compared with type 1 diabetes, although prevalent in both groups. Early monitoring and more active treatment of type 2 diabetes in young individuals is required.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom